ARCHIVES

Study Finds That CTC Was Used Correctly In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

WHT Participants Get “Phase Out” Help

March 11, 1988

NCI Begins TAILORx Study.

May 26, 2006

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

NCI Advisory Group, Other Cancer Meetings

February 22, 1985